Incidence of cancer in children has increased in recent decades, and known risk factors can account for only a small minority of cases. Gestation and early childhood are particularly vulnerable periods in human development and an important aspect of development is in circadian rhythmicity. Emerging evidence implicates the molecular circadian mechanism in a vast array of other physiologic functions including metabolism, DNA damage response and cell-cycle regulation. Electric light exposure at night can disrupt circadian rhythms and, thereby, many other physiologic processes that are under circadian control. On this basis, it is proposed that ill-timed electric light exposure to pregnant women, to neonates, infants, and small children may increase cancer risk in those children. There are practical implications and interventions that accrue from this idea should it later be confirmed to be true. Cancer Epidemiol Biomarkers Prev; 21(5); 701–4. ©2012 AACR.

The incidence of cancer in children has increased since the mid-1970s in the United States (1) and in Europe (2) where increases have occurred for each of the major diagnostic categories of leukemias (0.6% per year), lymphomas (0.9% per year), and central nervous system (CNS; intracranial) tumors (1.7% per year). There is also a rough correlation among societies between leukemia incidence in children and degree of industrialization; although known risk factors can account for only a minority of cases (3).

Gestation and early life are particularly vulnerable periods in human development, and establishment of circadian rhythmicity is a crucial part of a healthy development. Human circadian rhythmicity begins forming in early gestation but is not robust at birth and takes several more months to become consolidated (4). In the modern world, electric light, which can disrupt circadian rhythms, intrudes on nearly all aspects of life, from our very beginnings in utero, to our end. Maybe that is a problem (5).

Exposure to ill-timed electric light that disrupts circadian rhythmicity of a pregnant woman may alter circadian gene expression and may also alter circadian hormones relevant to cancer. For her fetus, who is exposed to the disruption as well, this might later lead to increased risk of cancer. After birth, ill-timed electric light exposure to a child may disrupt circadian rhythmicity and contribute to increased risk of cancer in early life.

Trichopoulos (6) reasoned that factors that might increase circulating estrogen in a pregnant woman might increase the lifetime risk of breast cancer in her daughter. A growing number of epidemiologic studies of predictions of this idea (e.g., high birth weight, pre-eclampsia, twin birth) lend support to it. Another prediction tested in rats by Hilakivi-Clarke and colleagues (7) was that maternal ethanol ingestion during pregnancy (far below that required to cause fetal alcohol syndrome) would increase mammary tissue development and susceptibility to chemically induced mammary tumorigenesis in her female pups later in life; both were confirmed in their experimental model.

By analogy, maternal exposure to electric light during the night might also cause changes in fetal development such that potential for malignant transformation is stimulated in hematopoietic and CNS tissues as well as in mammary tissue.

There are many biologic rhythms in humans with periods ranging from milliseconds as in nerve cells, to many weeks as in the menstrual cycle (8). Circadian rhythmicity (comprising many coordinated rhythms) includes endogenous, approximately 24-hour oscillations in melatonin production, activity, sleep, metabolism, body temperature, gene expression, and many other aspects of physiology; they continue to oscillate in the temporal isolation of constant darkness (9). Circadian rhythms are maintained in nature at exactly 24 hours by the sun. However, in the modern world, light and dark are increasingly determined by electric light inside buildings, and not by the solar cycle of day and night. Light is the major determinant of circadian entrainment (10), although meal timing can also play an important role in many organs (11). It has become clear that circadian rhythmicity can be severely disrupted by ill-timed exposure to electric light (12).

Monochromatic light during the night under experimental conditions was shown by Brainard and colleagues (13) to suppress circulating melatonin concentrations in humans in a dose-dependent manner with a peak effectiveness at about 460 nm (blue) and very little impact at 600 nm (red); even very low light intensity at short wavelengths exhibited a measurable lowering of blood melatonin level. For polychromatic light as used in buildings, it has recently been shown that even a relatively low level (60–130 lux) from a standard fluorescent bulb in the evening can delay the melatonin onset and blunt its amplitude in human subjects (14). Altered timing of light exposure can also change expression of circadian genes (15).

The 24-hour time course of expression of the clock genes (of which there are less than 10 so far identified; ref. 16) has been described in humans and will be important in helping unravel the connections of these genes to the control of so many aspects of our physiology (17). As much as 10% of human genes are under circadian control (16); of particular interest is the fact that many of these are genes of cell-cycle regulation and apoptosis. Importantly, it has become evident that the circadian clock mechanism is closely intertwined with cell-cycle regulation at the molecular level (18), and so circadian disruption can be expected to result in cell-cycle disruption as well. As with cancer in adults, cancer in children is a highly heterogeneous group of diagnoses (2); however, as the rubric “cancer” denotes, these diagnoses share certain features in common, high on the list of which is loss of cell-cycle control (19).

Early environmental exposures can effect epigenetic changes that may last a lifetime (20). In particular, epigenetic modification of gene expression may be an important link between the circadian system and metabolism, with the gene CLOCK playing a central role (21). The first epidemiologic evidence showing an environmental influence on epigenetic modification of CLOCK reported that shift working women display significant hypomethylation of the CLOCK promoter compared with day-working women; a finding consistent with previous reports of CLOCK promoter hypomethylation in women with breast cancer (22). An interesting question is whether shift work by a pregnant woman might have epigenetic consequences for her child that could affect fetal growth and development.

High birth weight has been consistently shown to be associated with risk of leukemia in children, and Ross appropriately asks “…should we work to understand mechanistically how birth weight and fetal growth are related to leukemia risk?” (23) Evidently maternal prepregnancy weight and pregnancy weight gain are associated with the birth weight of baby (24). Perhaps, birth weight reflects, in part, maternal circadian disruption which leads to her elevated weight. This might occur from a perturbation of metabolism from the circadian disruption (21) which could also manifest as short and disrupted sleep (25).

Circulating melatonin level is a robust marker of circadian rhythmicity in mammals, including humans. Melatonin plays a crucial role in maintenance and manifestation of circadian rhythmicity and has potent physiologic impacts of its own. It has been shown to have powerful antitumor activity in rodent experiments on the effect of light-at-night on growth of a human breast cancer xenograft (26). However, there is a paucity of data on a possible role of melatonin in etiology of childhood cancers.

For cancer in general, the time from the beginning of the carcinogenic process to the diagnosis of cancer is believed to be long. This does not mean that an exposure that causes a first mutation in a multistage pathway is the beginning of this process; even before that, factors which alter the normal growth and development of a tissue can have a large impact on later risk of cancer by changing the probability of mutations, either spontaneous or exposure-induced (27). There are a number of features of light-induced circadian disruption that could affect risk of cancer based not only on gene mutation but also alterations in the physiology of normal tissue (28).

Many of the leukemias diagnosed in children are thought to have originated in utero (29), as may be the case for many forms of cancer (30). Although as much as 1% of newborns show evidence of preleukemic t(12;21)-positive cells, a vastly lower percentage are ever diagnosed with B-cell acute lymphocytic leukemia (ALL), suggesting that other or exogenous factors are required to cause the clearance of these premalignant cells (31). Circadian disruption may impede this clearance process by compromising apoptotic pathways (32).

Perhaps of particular relevance to childhood leukemia, Méndez-Ferrer and colleagues (33) have shown that circulating hematopoietic stem cell (colony-forming units; CFU) concentrations in mice exhibit circadian fluctuations with a peak at 5 hours after beginning of the light period and a Nadir at 5 hours after lights out; the peak to nadir ratio was more than 5-fold. This pattern was obliterated by constant light, and total 24-hour concentrations were markedly higher. There is also evidence from study of infants that fetal hormone levels are strongly associated with markers of stem cell potential (30). This provides a possible link from circadian disruption, to stem cell concentration, to hormone levels in fetal development.

There are several facets to the possibility that disruption of circadian rhythms by electric light increases risk of cancer in children. These include in utero exposures to the mother, immediate postnatal exposure in the hospital, and lighting at home during early childhood.

Specific predictions of the hypothesis are as follows:

  • Maternal circadian disruption by light at night (e.g., from shift work) during pregnancy increases subsequent risk of cancer in her child.

  • Shorter gestation time increases risk because earlier birth, while infant circadian rhythmicity is still maturing, results in earlier exposure to the circadian disruptive effects of electric lighting, for example, in an NICU. There is some evidence in support of this for leukemia (34) and for CNS tumors (35); these studies focused on birth weight and risk but also report an inverse association of gestational age and risk.

  • Parental behaviors such as use of bright light at night for attending to a newborn infant increases risk of cancer for that child. Use of night lights in a child's bedroom increases risk.

Of all the terrible forms that cancer can take, cancer in a child is the most distressing. If the idea that electric lighting plays a role turns out to have merit (be true), then there are a number of practical implications and feasible interventions that could be implemented. For pregnant women, avoid shift work if possible and stick to a constant diurnal pattern of light exposure with sunlight during the day and as dark as possible during the night. For care of premature newborns, maintain as nearly as possible a diurnal pattern of lighting in the hospital; use light only where needed and only as bright as required for care. For parents of a child, from birth onward, avoid night lights, and when feeding or caring for a child at night, use dim red light sources.

No potential conflicts of interests were disclosed.

Conception and design: R.G. Stevens

Writing, review, and/or revision of the manuscript: R.G. Stevens

This article was written in preparation for the conference “Childhood Cancer 2012 - Early exposures and childhood cancer,” sponsored by the charity “CHILDREN with CANCER UK,” April 24 to 26, 2012, in London, UK.

1.
Ries
LAG
,
Melbert
D
,
Krapcho
M
,
editors
. 
SEER cancer statistics review, 1975–2004
,
Bethesda, MD
:
National Cancer Institute
.
Available from
: http://seer.cancer.gov/csr/1975_2004/, 2007.
2.
Kaatsch
P
. 
Epidemiology of childhood cancer
.
Cancer Treat Rev
2010
;
36
:
277
85
.
3.
Eden
T
. 
Aetiology of childhood leukaemia
.
Cancer Treat Rev
2010
;
36
:
286
97
.
4.
Rivkees
SA
. 
Developing circadian rhythmicity in infants
.
Pediatrics
2003
;
112
:
373
81
.
5.
Stevens
RG
. 
Electric light causes cancer? Surely you're joking, Mr. Stevens
.
Mutat Res Rev
2009
;
682
:
1
6
.
6.
Trichopoulos
D
. 
Hypothesis: does breast cancer originate in utero?
Lancet
1990
;
335
:
939
40
.
7.
Hilakivi-Clarke
L
,
Cabanes
A
,
de Assis
S
,
Wang
M
,
Khan
G
,
Shoemaker
WJ
, et al
In utero alcohol exposure increases mammary tumorigenesis in rats
.
Br J Cancer
2004
;
90
:
2225
31
.
8.
Haus
E
,
Smolensky
M
. 
Biological clocks and shift work: circadian dysregulation and potential long-term effects
.
Cancer Causes Control
2006
;
17
:
489
500
.
9.
Czeisler
CA
,
Duffy
JF
,
Shanahan
TL
,
Brown
EN
,
Mitchell
JF
,
Rimmer
DW
, et al
Stability, precision, and near-24-hour period of the human circadian pacemaker
.
Science
1999
;
284
:
2177
81
.
10.
Provencio
I
. 
Shedding light on photoperiodism
.
Proc Natl Acad Sci U S A
2010
;
107
:
15662
3
.
11.
Suter
DM
,
Schibler
U
. 
Physiology. Feeding the clock
.
Science
2009
;
326
:
378
9
.
12.
Lockley
SW
,
Brainard
GC
,
Czeisler
CA
. 
High sensitivity of the human circadian melatonin rhythm to resetting by short wavelength light
.
J Clin Endocrinol Metab
2003
;
88
:
4502
5
.
13.
Brainard
GC
,
Hanifin
JP
,
Greeson
JM
,
Byrne
B
,
Glickman
G
,
Gerner
E
, et al
Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor
.
J Neurosci
2001
;
21
:
6405
12
.
14.
Gooley
JJ
,
Chamberlain
K
,
Smith
KA
,
Khalsa
SB
,
Rajaratnam
SM
,
Van Reen
E
, et al
Exposure to room light before bedtime suppresses melatonin onset and shortens melatonin duration in humans
.
J Clin Endocrinol Metab
2011
;
96
:
E463
72
.
15.
James
FO
,
Cermakian
N
,
Boivin
DB
. 
Circadian rhythms of melatonin, cortisol, and clock gene expression during simulated night shift work
.
Sleep
2007
;
30
:
1427
36
.
16.
Takahashi
JS
,
Hong
HK
,
Ko
CH
,
McDearmon
EL
. 
The genetics of mammalian circadian order and disorder: implications for physiology and disease
.
Nat Rev Genet
2008
;
9
:
764
75
.
17.
Bjarnason
GA
,
Jordan
RC
,
Wood
PA
,
Li
Q
,
Lincoln
DW
,
Sothern
RB
, et al
Circadian expression of clock genes in human oral mucosa and skin: association with specific cell-cycle phases
.
Am J Pathol
2001
;
158
:
1793
801
.
18.
Hunt
T
,
Sassone-Corsi
P
. 
Riding tandem: circadian clocks and the cell cycle
.
Cell
2007
;
129
:
461
4
.
19.
NCI
. 
What is Cancer?
Bethesda, MD
:
National Cancer Institute
.
Available from
: http://www.cancer.gov/cancertopics/cancerlibrary/what-is-cancer, 
2012
.
20.
Szyf
M
. 
Early life, the epigenome and human health
.
Acta Paediatr
2009
;
98
:
1082
4
.
21.
Bellet
MM
,
Sassone-Corsi
P
. 
Mammalian circadian clock and metabolism - the epigenetic link
.
J Cell Sci
2010
;
123
:
3837
48
.
22.
Zhu
Y
,
Stevens
RG
,
Hoffman
AE
,
Tjonneland
A
,
Vogel
UB
,
Zheng
T
, et al
Epigenetic impact of long-term shiftwork: pilot evidence from circadian genes and whole-genome methylation analysis
.
Chronobiol Int
2011
;
28
:
852
61
.
23.
Ross
JA
. 
Birth weight and childhood leukemia: time to tackle bigger lessons
.
Pediatr Blood Cancer
2012
;
58
:
1
2
.
24.
Stamnes
Koepp UM
,
Frost
Andersen L
,
Dahl-Joergensen
K
,
Stigum
H
,
Nass
O
,
Nystad
W
. 
Maternal pre-pregnant body mass index, maternal weight change and offspring birthweight
.
Acta Obstet Gynecol Scand
2012
;
91
:
243
9
.
25.
Hanlon
EC
,
Van Cauter
E
. 
Quantification of sleep behavior and of its impact on the cross-talk between the brain and peripheral metabolism
.
Proc Natl Acad Sci
2011
;
108
Suppl 3
:
15609
16
.
26.
Blask
DE
,
Brainard
GC
,
Dauchy
RT
,
Hanifin
JP
,
Davidson
LK
,
Krause
JA
, et al
Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats
.
Cancer Res
2005
;
65
:
11174
84
.
27.
Moolgavkar
SH
,
Knudson
AG
 Jr
. 
Mutation and cancer: a model for human carcinogenesis
.
J Natl Cancer Inst
1981
;
66
:
1037
52
.
28.
Stevens
RG
,
Blask
DE
,
Brainard
GC
,
Hansen
J
,
Lockley
SW
,
Provencio
I
, et al
Meeting report: the role of environmental lighting and circadian disruption in cancer and other diseases
.
Environ Health Perspect
2007
;
115
:
1357
62
.
29.
Greaves
MF
,
Wiemels
J
. 
Origins of chromosome translocations in childhood leukaemia
.
Nat Rev Cancer
2003
;
3
:
639
49
.
30.
Baik
I
,
Devito
WJ
,
Ballen
K
,
Becker
PS
,
Okulicz
W
,
Liu
Q
, et al
Association of fetal hormone levels with stem cell potential: evidence for early life roots of human cancer
.
Cancer Res
2005
;
65
:
358
63
.
31.
Lausten-Thomsen
U
,
Madesn
HO
,
Vestergaard
TR
,
Hjalgrim
H
,
Lando
A
,
Schmiegelow
K
. 
Increased risk of ALL among premature infants is not explained by increased prevalence of pre-leukemic cell clones
.
Blood Cells Mol Dis
2010
;
44
:
188
90
.
32.
Sancar
A
,
Lindsey-Boltz
LA
,
Kang
TH
,
Reardon
JT
,
Lee
JH
,
Ozturk
N
. 
Circadian clock control of the cellular response to DNA damage
.
FEBS Lett
2010
;
584
:
2618
25
.
33.
Méndez-Ferrer
S
,
Lucas
D
,
Battista
M
,
Frenette
PS
. 
Haematopoietic stem cell release is regulated by circadian oscillations
.
Nature
2008
;
452
:
442
7
.
34.
Hjalgrim
LL
,
Rostgaard
K
,
Hjalgrim
H
,
Westergaard
T
,
Thomassen
H
,
Forestier
E
, et al
Birth weight and risk for childhood leukemia in Denmark, Sweden, Norway, and Iceland
.
J Natl Cancer Inst
2004
;
96
:
1549
56
.
35.
Schmidt
LS
,
Schüz
J
,
Lähteenmäki
P
,
Träger
C
,
Stokland
T
,
Gustafson
G
, et al
Fetal growth, preterm birth, neonatal stress and risk for CNS tumors in children: a Nordic population- and register-based case-control study
.
Cancer Epidemiol Biomarkers Prev
2010
;
19
:
1042
52
.